BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17174516)

  • 1. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
    Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
    Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
    Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: role of CEA and CA 19-9.
    Weissenberger C; Von Plehn G; Otto F; Barke A; Momm F; Geissler M
    Anticancer Res; 2005; 25(3A):1787-93. PubMed ID: 16033101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in patients with gastric carcinoma.
    Janssen CW; Orjasaeter H
    Eur J Surg Oncol; 1986 Mar; 12(1):19-23. PubMed ID: 3956751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
    Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.
    Bruns F; Micke O; Halek G; Schäfer U; Willich N
    Anticancer Res; 2003; 23(2A):1103-6. PubMed ID: 12820355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
    Forones NM; Tanaka M
    Hepatogastroenterology; 1999; 46(26):905-8. PubMed ID: 10370636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto S; Akasu T; Fujita S; Moriya Y
    Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
    Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
    Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma.
    Min BS; Kim NK; Sohn SK; Cho CH; Lee KY; Baik SH
    J Surg Oncol; 2008 Feb; 97(2):136-40. PubMed ID: 17963247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.